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ABSTRACT
clerosing mesenterit is  (SM) is  a rare 
clinicopathological condition that affects the Smesentery of the small bowel and occasionally 
the mesocolon. It is largely an idiopathic condition 
characterized by nonspecific inflammation of the 
1mesenteric adipose tissue . It was first described by 
Jura in 1924 as “retractile mesenteritis” and further 
labeled as “mesenteric panniculitis” by Odgen later in 
2-4the 1960s . Numerous terms have been used to 
describe this condition based on the most predominant 
histological picture. They include: mesenteric 
lipodystrophy (when fatty degeneration and necrosis 
predominate), mesenteric panniculitis (when there is 
marked chronic inflammation involving the adipose 
tissue), and retractile mesenteritis or mesenteric 
3,4fibrosis (if fibrosis is predominant) . Other names that 
have been used for this disorder in the literature 
include mesenteric sclerosis, liposclerotic mesenteritis, 
mesenteric Pfeifer-Weber-Christian disease, 
mesenteric lipogranuloma, and xanthogranulomatous 
2,5,6mesenteritis . Today most articles describe the 
pathologic condition as "sclerosing mesenteritis", and 
divide it into three major phases of the same pathologic 
condition, each regarding a progressively worsening 
state. The pathologic findings begin with fat necrosis 
and end with regenerative fibrosis. Within this 
progress of disease state, fat necrosis predominates in 
the first step, therefore, called mesenteric 
lipodystrophy. This is then followed by mesenteric 
panniculitis, characterized by intense inflammatory 
reaction, and lastly by retractile mesenteritis, when 
4fibrosis becomes the main feature . 
Sclerosing mesenteritis may be totally assymptomatic, 
discovered incidentally during routine investigation 
3,7for other conditions . It has been described as a benign, 
self-limited disorder with a favorable prognosis that 
8may even resolve spontaneously . It may in some cases 
3be potentially severe and debilitating . The most 
common symptom associated with sclerosing 
3mesenteritis is abdominal pain, which can be severe . 
Some individuals may have a palpable abdominal 
mass and affected individuals may develop small 
3bowel obstruction or acute abdomen . A high index of 
suspicion is needed to suspect this rare entity 
5clinically . Abdominal CT is currently being proposed 
9as an effective method for diagnostic evaluation . The 
definite diagnosis of sclerosing mesenteritis is 
3,6established by biopsy . Most symptomatic patients 
might benefit from medical therapy with a variety of 
d r u g s  i n c l u d i n g  s t e r o i d s ,  t h a l i d o m i d e ,  
cyclophosphamide, methotrexate, progesterone, 
colchicine, azathioprine, tamoxifen, antibiotics and 
emetine, or radiotherapy, with different degrees of 
2,3,6success . Surgical exploration is however indicated in 
patients with intractable complications like intestinal 
3obstruction and acute abdomen . 
INTRODUCTION
Sclerosing mesenteritis (SM) is a rare idiopathic disorder characterized by chronic non-specific inflammation 
involving the adipose tissue of the bowel mesentery. It may be asymptomatic but it commonly presents with 
abdominal pain. Some individuals may have a palpable abdominal mass and affected individuals may develop small 
bowel obstruction or acute abdomen. 
We report a case of 27-year old man who presented to the Surgery Department at Chukwuemeka Odimegwu 
Ojukwu University Teaching Hospital (COOUTH), Amaku-Awka, Anambra State with acute abdomen and intestinal 
obstruction. He subsequently, had a surgical resection, which was histologically confirmed as a sclerosing 
mesenteritis. Sclerosing mesenteritis is a rare disorder and this is the first case being reported in the literature from 
South-East, Nigeria. It is therefore, important to alert physicians, more especially the surgeons on the need to have a 
high index of suspicion in every case of intestinal obstruction.
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of bowel loops with surrounding fluid collection in the 
pelvis and lower abdomen. An impression of ruptured 
appendix with appendix mass and abscess was made. 
Patient was worked up for emergency exploratory 
laparotomy. Intra-operative findings were: retraction 
and distortion of the loops of ileum, caecum and 
omentum and the formation of adhesions between 
them. There was what seemed as walling off an abscess 
cavity on the pelvis and right lower abdomen; 
thickening and sclerosis of the terminal 30cm of ileum 
with patchy degenerative changes of the affected loop 
of ileum and mesentery. There was also presence of 
enlarged mesenteric lymph nodes.
Right hemicolectomy with resection of terminal 30cm 
of the ileum was done. Patient was placed on broad-
specrum intravenous antibiotics. The post-operative 
recovery was uneventful. Histology of the resected 
specimen showed mesenteric tissue infiltrated by 
inflammatory cells, myofibroblasts and foamy 
macrophages with associated infiltration and 
thrombosis of the vessels traversing the lesion. There 
was extensive fibrosis with hyalinization, chronic 
inflammation and fat necrosis surrounded by clusters 
of foamy macrophages and reactive lymph nodes form 
islands in the sea of fibrosis and sclerosis. The colon 
showed focal haemorrhagic infarction. All the lymph 
nodes isolated showed reactive changes ranging from 
follicular hyperplasia to intense sinuous histiocytosis. 
The overall features are in keeping with a sclerosing 
mesenteritis (figure 1).
CASE REPORT:
We report a case of a 27-year old man presenting with 2-
week history of severe abdominal pain, 1-week history 
of abdominal distension and 2-day history of nausea, 
vomiting and constipation. Abdominal pain was 
generalized, but more on the right lower abdomen. 
Prior to the onset of severe abdominal pain, patient had 
been experiencing intermittent right lower abdominal 
pain for more than a year. For this reason, he was 
admitted in a private hospital where a provisional 
diagnosis of acute appendicitis was made. Laparotomy 
was performed; however, intra-operatively an 
impression of appendix mass was made. The surgical 
wound was closed without tempering with the 
appendix and the patient placed on antibiotics hoping 
to be operatated on a later date. Thereafter, patient 
improved though he still complained of occasional 
right lower abdominal pain which later became severe 
2 weeks prior to presentation to our facility.
On examination, patient was in painful distress, febrile 
to touch, mildly dehydrated, not pale and anicteric. The 
pulse rate was 92 beats/minute and the Blood pressure 
was 130/70mmHg. The abdomen was distended with 
generalized tenderness and guarding more on right 
iliac fossa and suprapubic regions. 
Investigations performed showed leucocytosis with 
relative neutrophilia,   the haemogoblin concentration 
was 12g/dl, and HIV screening was non-reactive. 
Abdominal ultrasonography showed a complex mass 
lymphoid follicles.
Patient has been on follow up visits for 6 months and 
has remained symptomless. Post-operative abdominal 
CT scan was requested for but yet to be done due to 
financial constraint.
Figure 1 Sclerosing Mesenteritis. A, Low power view 
showing reactive lymphoid follicles with prominent 
germinal centres forming an island on a background of 
sclerosing fibrosis. B, There is replacement of fat 
lobules by extensive sclerosis, fibrosis, and 
inflammatory infiltrates of foam cells and 
lymphocytes, sharply demarcating the reactive 
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DISCUSSION:
Sclerosing mesenteritis (SM) is a rare idiopathic 
disorder characterized by chronic non-specific 
inflammation involving the adipose tissue of the bowel 
1mesentery . The condition has been described as rare 
but may actually be under diagnosed due to the relative 
ignorance of the condition amongst both surgeons and 
5radiologists . Less than 300 cases have been reported in 
the world-wide literature under several names: 
retractile mesenteritis, sclerosing mesenteritis, 
mesenteric panniculitis, liposclerotic mesenteritis, 
isolated lipodystrophy of the mesentery, mesenteric 
lipomatosis, and lipogranuloma of the mesentery, and 
mesenteric manifestations of Weber-Christian 
2,4,5,9disease . Only a few large series have been published 
3,10-12in world literature  most other published reports are 
2,5,6of small case series  or single patients like the current 
case. Due to the paucity of published cases there is 
limited information on the exact cause, the etiological 
factors, the natural history, the prognosis, and the 
3,6treatment options of patients with SM . Sclerosing 
mesenteritis is a disease of middle-aged or older adults, 
diagnosed primarily during the 6th–7th decade of life, 
3,6,8the incidence increases with age . Paediatrics cases 
are very uncommon, probably because children have 
2,6less mesenteric fat than adults. . The disease appears to 
2,3,6,8be twice as common in men as in women . Our index 
patient is a male and relatively younger than the 
usually finding in most cases.
The disease is often asymptomatic and indeed most 
patients in any given series were incidentally identified 
6,9during a CT examination . Most symptoms associated 
with SM are caused by the direct mechanical effect of 
the mesenteric mass encasing the bowel, blood vessels 
6and lymphatics . The most common symptom 
associated with sclerosing mesenteritis is abdominal 
3pain, which can be severe . Other symptoms include: 
nausea, vomiting, constipation, diarrhea, fatigue, 
malaise, fever, night sweats, abdominal distention, loss 
3 3of appetite, and weight loss . Akram et al  found the 
most frequent presenting symptoms to be abdominal 
pain in 70%, bloating and distention in 26%, diarrhea in 
25%, weight loss in 23%, nausea and vomiting in 21%, 
anorexia in 16%, constipation in 15%, fever in 6% and 
1night sweats in 3%. Rajendran and Duerksen  
presented a case of SM manifesting as protein loosing 
enteropathy with features of diarrhea and peripheral 
oedema. In some cases, affected individuals may 
develop small bowel obstruction or acute abdomen 
with abdominal tenderness, palpable abdominal mass 
3and chylous ascites.  Our index patient presented with 
features suggestive of acute abdomen and intestinal 
obstruction: severe abdominal pains and distension, 
nausea, vomiting, constipation and fever.
The exact cause of sclerosing mesenteritis is 
1,6idiopathic . The pathogenic mechanism seems to be a 
6non-specific response to a wide variety of stimuli.  
Some individuals with sclerosing mesenteritis have 
3,12 12had prior abdominal surgery or trauma . Emory et al  
reported 84% of their patients had a history of previous 
3abdominal trauma or surgery. Akram et al  reported a 
history of abdominal surgery in about 35% of their 
patients. The patient in this index case had a year 
history of an attempted appendicectomy which was 
abandoned because of finding of what appeared as an 
appendix mass. Some researchers have proposed that 
sclerosing mesenteritis is associated with autoimmune 
9disorder  but no study has been able to substantiate the 
claim. Some individuals with sclerosing mesenteritis 
have had an underlying form of cancer (malignancy) 
such as lymphoma, Hodgkin disease, leukemia, gastric 
9carcinoma or colon cancer. Daskalogiannaki et al  
found an association of SM and malignancy in 69.4% of 
their patient but more than half of the cases were extra-
13abdominal in location. Wikes et al  discovered 
malignancy in 38% of their 108 patients mostly 
colorectal, lymphoma and urogenital tract in that 
6order. Vlachos et al  found colon cancer in 60% of the 5 
cases they studied. In other reports, no increase in the 
14occurrence of cancer is seen . Some other researchers 
have speculated that, in some cases, sclerosing 
13mesenteritis may be a paraneoplastic syndrome .
Individuals with sclerosing mesenteritis have a soft-
tissue mass that is detectable by radiographic study 
such as abdominal ultrasound, computerized 
tomography (CT) scanning or magnetic resonance 
imaging (MRI). Ultrasound typically demonstrates 
distortion and thickening of the root of the mesentery 
with slight decrease in echogenicity. Mass effect may be 
evident. A halo of sparing around vessels may be also 
seen on ultrasound as a region of hyperechoic fat. 
Abdominal CT has been proposed as the standard 
9diagnostic radiological investigation . CT criteria for 
the diagnosis of SM were the following: a solitary well-
defined mass composed of inhomogeneous fatty tissue 
with attenuation values higher than those of the 
retroperitoneal fat at the root of the small-bowel 
mesentery, engulfment of superior mesenteric vessels 
without vascular involvement, and no evidence of 
invasion of the adjacent small-bowel loops even if 
9displaced . Our patient was only able to do abdominal 
ultrasound which showed a complex mass of bowel 
loops with surrounding fluid collection in the pelvis 
and lower abdomen, suggesting probably a ruptured 
appendix with a mass and abscess. The definite 
diagnosis of SM is established by biopsy. Variable 
combinations of foci of fat degeneration and necrosis, a 
nonspecific and predominantly lymphocytic 
inflammatory infiltrate and fibrosis have been 
3,8reported .
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There is still no general consensus on the treatment of 
3,6SM . Treatment is reserved for the symptomatic cases. 
Asymptomatic cases are usually observed over time. A 
lot of authors have reported good response of 
symptomatic cases to a variety of anti-inflammatory, 
immunomodulatory, and antifibrotic agents like 
s tero ids ,  tha l idomide ,  cyc lophosphamide ,  
methotrexate, progesterone, colchicine, azathioprine, 
3,6tamoxifen . Surgical exploration and resections has 
been reserved for those with intractable complications 
like acute abdomen or intestinal obstruction or when 
other indications for abdominal exploration cannot be 
3ruled out .  However attempted surgical resection or 
debulking usually does not result in resolution of the 
3,6symptoms or prevent disease progression . The 
patient in this case study only received bowel resection 
and has remained asymptomatic for more than six 
months after.
CONCLUSION
Sclerosing mesenteritis can manifest as acute abdomen 
or intestinal obstruction. A high index of suspicion is 
needed in making the diagnosis and confirmation of 
diagnosis is by biopsy. Surgical exploration and 
resection is still useful in complicated cases.
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